Position in BMY
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$9,339,164
-$750,691 QoQ
Shares Held
162,082
-2.6% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.72%
of 13F equity value
Holder Rank
#406
of 2,506 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Stonebridge Capital Advisors LLC holds $79,452,749 across 7 Drug Manufacturers - General names. BMY ranks #5 (11.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
86,589 | $21,991,008 | |
| 2 | MRK |
Merck & Co., Inc.
|
148,656 | $19,102,296 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
112,875 | $14,260,627 | |
| 4 | LLY |
ELI LILLY & Co
|
11,574 | $13,882,203 | |
| 5 | BMY |
Bristol Myers Squibb Co
This page
|
162,082 | $9,339,164 | |
| 6 | PFE |
Pfizer Inc
|
20,095 | $483,887 | |
| 7 | ABBV |
AbbVie Inc.
|
1,564 | $393,564 |
All Filings in BMY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,339,164 | 162,082 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $10,089,855 | 166,362 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $9,228,864 | 171,095 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $7,969,891 | 176,716 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $8,593,969 | 185,655 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $11,223,562 | 184,023 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $10,551,381 | 186,552 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $9,655,563 | 186,617 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $7,696,048 | 185,313 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $10,668,017 | 196,718 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $9,595,893 | 187,018 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $10,342,495 | 178,196 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $10,901,556 | 170,470 | Shares | Sole | 2023-08-23 | |
| 2023-03-31 | $11,045,588 | 159,365 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $11,484,515 | 159,618 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $11,311,982 | 159,122 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $12,273,800 | 159,400 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $11,785,654 | 161,381 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $9,922,877 | 159,148 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $8,532,077 | 144,196 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $8,667,823 | 129,719 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $8,189,160 | 129,719 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $7,293,983 | 117,588 | Shares | Sole | 2021-03-05 | |
| 2020-09-30 | $6,920,327 | 114,784 | Shares | Sole | 2020-11-18 | |
| 2020-06-30 | $6,632,816 | 112,803 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $6,401,683 | 114,849 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||